Clinical Library

This paper, written by Ryan Gabriel, MD, explores the diagnostic use of Contrast Enhanced Mammography and discusses the clinical and workflow considerations of an Affirm R Contrast Biopsy procedure.  

This paper written by Andrew Smith, PhD, Vice President Breast Health R&D, documents several methods by which users of Hologic I-View software may biopsy lesions seen in contrast images using stereotactic methods  

In this article, the authors hypothesized that the surface roughness of the biopsy clips will elicit a twinkling signature on color Doppler making them more readily identifiable by ultrasound.   Please visit PubMed to view the full article *This article is intended for medical professionals in the United States

Authored by Jason McKellop, MD, this white paper will discuss his experience at Beverly Radiology Medical Group, Breastlink Tarzana as they adopted high resolution imaging with 3DQuorum® technology.

The article is intended to assess the injection techniques in contrast imaging. Please visit PubMed for the full text article.

A retrospective single-center study assessing the early and late infectious complications from BioZorb placement as well as the noninfectious complications, including device migration, reoperation to remove BioZorb, and development of hematoma or seroma. Please visit PubMed for the full text article.

Authored by Brad Keller, Ph.D, Director, Clinical Research Breast Health, Hologic, Inc., Ashwini Kshirsagar, Ph.D, Chief Scientist, Clinical Solutions, Research and Development, Hologic, Inc. and Andrew Smith, Ph.D., Vice President, Image Research Breast Health, Hologic. Inc.  This whitepaper documents how radiologists demonstrated clinical superiority,measured by significantly increased area under the ROC curve, when reviewing tomosynthesis cases with the Genius AI Detection information compared to reviewing the cases without the information.

Authored by Kamilia Kozlowski, MD, Medical Director and CEO of Knoxville Comprehensive Breast Center, Knoxville, Tennesse. This whitepaper documents how using SWE to evaluate breast tissue alongside high-definition ultrasound images creates a very strong confidence in our ultrasound screening conclusions.

Brad Keller, Ph.D, Director, Clinical Research Breast Health, Hologic, Inc., Ashwini Kshirsagar, Ph.D, Chief Scientist, Clinical Solutions, Research and Development, Hologic, Inc. and Andrew Smith, Ph.D., Vice President, Image Research Breast Health, Hologic. Inc.  This whitepaper documents how Hologic's product, 3DQuorum 6-mm slices known as SmartSlices can significantly reduce the number of slices and file sizes in a tomosynthesis dataset, while maintaining clinical performance compared to 1-mm datasets. The fewer number of total slices in the study allows a decrease in radiologist interpretation time, saving on average 1 hour per reader in an 8-hour day.

Authored by Cary S. Kaufman, MD, FACS, this white paper will discuss his decision to replace the use of surgical clips to mark the lumpectomy excision site with a bioabsorbable implant that serves as both a surgical marker for future medical procedures (such as radiation targeting, radiation therapy planning, mammographic follow-up, etc.), and as a scaff old to support tissue healing and breast contour (BioZorb® 3D Bioabsorbable Marker).

  Authored by Georgia Giakoumis Spear, M.D., this white paper will discuss her experience at NorthShore University Health System as they adopted proven technological advances to increase their ability to detect breast cancers at the earliest stage.  

This article is intended to compare case delays in all patients undergoing breast conserving surgery (BCS) with wire localization in 2017 with all patients undergoing BCS with a radiofrequency identification tag system.   Please visit PubMed for the full text article.